Tag Archives: OncoSec Medical

OncoSec Medical (ONCS) Receives a Buy from Maxim Group

In a report released yesterday, Jason McCarthy from Maxim Group assigned a Buy rating to OncoSec Medical (ONCS – Research Report), with a price target of $5.00. The company’s shares closed last Tuesday at $4.09. According to TipRanks.com, McCarthy is

Ladenburg Thalmann & Co. initiated Buy on OncoSec Medical Shares, Sees 100% Upside For The Stock

In a research report sent to investors on Monday, Ladenburg Thalmann & Co. analyst Robert LeBoyer initiated Buy rating on OncoSec Medical (NASDAQ:ONCS)with a price target of $8, which implies an upside of 100% from current levels. According to TipRanks.com,

Analysts’ Top Services Picks: OncoSec Medical (ONCS), Pareteum Corp (TEUM)

There’s a lot to be optimistic about in the Services sector as 2 analysts just weighed in on OncoSec Medical (ONCS – Research Report) and Pareteum Corp (TEUM – Research Report) with bullish sentiments. OncoSec Medical (ONCS) Maxim Group analyst

Maxim Group Maintains Their Buy Rating on OncoSec Medical (ONCS)

Maxim Group analyst Jason McCarthy maintained a Buy rating on OncoSec Medical (ONCS – Research Report) today and set a price target of $5. The company’s shares opened today at $0.59, close to its 52-week low of $0.42. McCarthy observed:

Analyst Explains Why They Downgraded Their Rating on OncoSec Medical (ONCS)

In a report released today, Ram Selvaraju from H.C. Wainwright downgraded OncoSec Medical (ONCS – Research Report) to Hold, with a price target of $1. The company’s shares closed yesterday at $0.87, close to its 52-week low of $0.68. Selvaraju

OncoSec Medical (ONCS) Gets a Buy Rating from Maxim Group

In a report released today, Jason McCarthy from Maxim Group maintained a Buy rating on OncoSec Medical (ONCS – Research Report), with a price target of $5. The company’s shares opened today at $0.79, close to its 52-week low of